About MIRECULE, INC.
miRecule is a biotechnology company developing RNA therapies for cancer and muscular dystrophy using genomic patient data to create tailored therapeutics. The company utilizes its proprietary DREAmiR™ platform to identify genetic changes and develop novel RNA therapeutics.
Development of RNA therapies for cancer and muscular dystrophyUse of genomic patient data for tailored therapeuticsProprietary DREAmiR™ platform for identifying genetic changes and creating RNA therapeuticsCollaboration with Sanofi on RNA therapeutics for rare diseasesIssuance of patents covering lead RNA therapeutics
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $305K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MIRECULE, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.